About: Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique (publié 2011) (fr) наукова стаття, опублікована в січні 2011 (uk) im Jahr 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2011 (ast) artikull shkencor i botuar më 01 janar 2011 (sq) scientific article published on 01 January 2011 (en)
publication date	wds:Q82214347-CE828A09-6616-4BF6-83D6-9A04248617FA
publication date	2011-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q82214347-5E2084B8-E047-4478-ADDC-BB6C9FFF8CED wds:Q82214347-65008BAB-0483-47F0-BC13-A9CFFF81BA86 wds:Q82214347-74778B83-AD80-40BD-BC32-C0EABC5A49ED wds:Q82214347-7A6EEED4-3E49-4DB4-B0F9-84316D58A830 wds:Q82214347-82A9C97E-ECE7-48B0-B9A9-AD8E892DFED1 wds:Q82214347-C3464327-509B-4F61-B85F-45D460E35F54 wds:Q82214347-E1F83C39-AD82-4A39-A2D0-C09B59D0A8B0
author name string	Bernhard O Boehm Marcus E Kleber Winfried März Bernhard R Winkelmann Robert L Wolfert Graciela Delgado De Moissl Simone Dietz
rdfs:label	Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (en) Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (nl) Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (sq)
skos:prefLabel	Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (en) Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (nl) Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (sq)
name	Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (en) Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (nl) Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (sq)
author	wds:Q82214347-500CC72A-6E8F-4DAC-A2AC-4D3880C104C8
author	Tanja B Grammer
title	wds:Q82214347-272C1D91-F32E-4C4D-89F6-056A8347A2C4
title	Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study) (en)
page(s)	wds:Q82214347-7ED6CE2B-BF4A-4A8A-947A-9C84C8C4501B
page(s)	659-667
instance of	wds:Q82214347-E856D687-E972-40F9-B130-0ACC3A261C40
instance of	scholarly article
PubMed ID	wds:Q82214347-08917EFE-3B9C-49C3-AD6B-E82AE8C00C6B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22029180
PubMed ID	22029180
published in	wds:Q82214347-3457B49D-84F7-4C48-9876-4A384EDAAB41
published in	Clinical Laboratory
issue	wds:Q82214347-B5347ABB-6A87-4769-9492-199A8641224C
volume	wds:Q82214347-5E74AE40-F696-4F42-A915-523968E102CC
issue	9-10
volume	57
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q82214347
is cites work of	Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease Determination of phospholipase activity of PAF acetylhydrolase Unraveling the PAF-AH/Lp-PLA2 controversy Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease. Association of lipoprotein-associated phospholipase A2 and risk of incident atrial fibrillation: Findings from 3 cohorts.
is cites work of	wds:Q43204699-C4CD0B5F-3E82-4AC2-B538-712D346EB4B1 wds:Q56985385-EEFAFC19-66EF-4214-B18E-F3938C3AE1AD wds:Q55186241-F0FFDF6E-CD37-455B-A9D7-231C339192F0 wds:Q36019971-230CF377-8DC9-4960-BF82-E035B9FF0176 wds:Q36240691-0E15F5B9-1EB8-4E22-B610-76D2592AEAB3 wds:Q49972109-D84FFA5F-B32A-46A7-80C9-733E1D9AA31E wds:Q37076194-C6B6E9BA-F959-4350-A244-A4A53FB9EBB3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software